Skip to content

Comparison of QIPB and SIFICB in Hip Surgery

Comparison of the Effects of Quadroiliac Plane Block Versus Suprainguinal Fascia Iliaca Compartment Block on Postoperative Pain in Hip Surgery

Status
Not yet recruiting
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT07233746
Enrollment
60
Registered
2025-11-18
Start date
2025-12-15
Completion date
2026-05-31
Last updated
2025-11-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Hip Surgery, Postoperative Pain

Keywords

postoperative pain, hip surgery, regional anesthesia, quadroiliac plane block, suprainguinal fascia iliaca compartment block

Brief summary

The aim is to compare the postoperative analgesic effects of Quadroiliac Plane Block (QIPB) and Suprainguinal Fascia Iliaca Compartment Block (SIFICB) in patients undergoing hip surgery.

Detailed description

Patients were divided into two randomized groups: Group 1 (QIPB group, n=30) and Group 2 (SIFICB group, n=30). All patients will receive the same standard general anesthesia per hospital protocol. All blocks will be applied with the same ultrasonography and block equipment, and by the same physician. After the anesthesia induction, patients in Group 1 will receive Quadroiliac Plane Block (QIPB) with 40 mL of 0.25% bupivacaine. Patients in Group 2 will receive Suprainguinal Fascia Iliaca Compartment Block (SIFICB) with 30 mL of 0.25% bupivacaine. All patients will receive Paracetamol 1gr and Dexketoprofen 50mg intravenous (IV) 10 minutes prior to skin closure. Routine analgesic procedure consisting of 3x400mg Ibuprofen will be followed postoperatively for 24 hours. Numeric Rating Scale (NRS) will be used to assess postoperative pain on 1st, 6th, 12th, 18th and 24th hours after the surgery. Tramadol 1mg/kg IV will be administered as a rescue analgesic for all patients if NRS score is higher than 4. Total Tramadol consumption will be calculated.

Interventions

PROCEDUREQuadro-İliac Plane Block(QİPB)

40 mL of 0.25% bupivacaine

PROCEDURESuprainguinal Fascia Iliaca Compartiment Block

30 mL of 0.25% bupivacaine

Sponsors

Cumhuriyet University
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
OTHER
Masking
QUADRUPLE (Subject, Caregiver, Investigator, Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
18 Years to 99 Years
Healthy volunteers
No

Inclusion criteria

* Adult patients over 18 years of age who underwent percutaneous nephrolithotomy under general anesthesia and were I-II-III according to the American Society of Anesthesiologists (ASA) risk classification were included in the study.

Exclusion criteria

* patients who did not give consent, * patients with coagulopathy, * patients with signs of infection at the block application site, * patients using anticoagulants, * patients with known allergies to any of the study drugs, * patients with unstable hemodynamics, * patients who could not cooperate during postoperative pain assessment * patients who wanted to withdraw from the study, * patients with alcohol and drug addiction, * patients with musculoskeletal abnormalitie

Design outcomes

Primary

MeasureTime frameDescription
Numeric Rating Scale (NRS) ScoresPostoperative 24 hoursNumerical rating scale is used for pain assessment. The scores of the numerical rating scale changes between 0 to 10 points. 10 points mean the most severe pain that the patient ever had. 0 point means there is no pain. Higher scores mean worse outcome.

Secondary

MeasureTime frameDescription
Total tramadol consumptionPostoperative 24 hoursPostoperative total analgesic need was recorded as milligram in unit.

Countries

Turkey (Türkiye)

Contacts

Primary ContactOĞUZ GÜNDOĞDU
droguzgundogdu@gmail.com+905545945469
Backup ContactMAHMUT K DEMİRCİ
mkdemirci1@gmail.com+905389700697

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026